HAOYUE CAPITAL

HAOYUE CAPITAL, founded in January 2014, is a leading investment bank in China that focuses on the healthcare industry. Headquartered in Shanghai, the company has regional offices in Beijing and Shenzhen. HAOYUE CAPITAL is committed to leveraging capital and research-driven insights to help outstanding enterprises in China's healthcare industry successfully access the capital markets and create added value for clients. The partnership team of HAOYUE CAPITAL consists of senior investment bankers with years of deep engagement in China’s healthcare sector. HAOYUE CAPITAL consistently tracks market dynamics and investment trends in healthcare, covering research areas and transaction scopes across multiple sub-sectors such as innovative pharmaceuticals, cutting-edge medical devices, IVD and life sciences, health services, and smart healthcare. As of 2022, HAOYUE CAPITAL has completed over 300 projects with a cumulative transaction value exceeding tens of billions of US dollars; including over 50 M&A and restructuring deals with a total transaction amount surpassing 5 billion US dollars. In 2022, HAOYUE CAPITAL completed more than 50 private equity financings, M&A integrations, and complex spin-off transactions from listed companies, with a total transaction value of several billion US dollars, maintaining comprehensive leadership across various subfields of the healthcare industry.